Now Is The Time To Build A Position In Unicycive Therapeutics Inc (NASDAQ:UNCY)

In the last trading session, 49.41 million Unicycive Therapeutics Inc (NASDAQ:UNCY) shares changed hands as the company’s beta touched 2.04. With the company’s per share price at $0.53 changed hands at -$0.37 or -40.88% during last session, the market valuation stood at $64.19M. UNCY’s last price was a discount, traded about -107.55% off its 52-week high of $1.10. The share price had its 52-week low at $0.20, which suggests the last value was 62.26% up since then.

Analysts gave the Unicycive Therapeutics Inc (UNCY) stock a consensus recommendation rating of Buy, calculated at a mean rating of 1.00. If we narrow down to specifics, the data shows that 0 out of 2 analysts rate the stock as a Sell, with a further 0 assigning it an Overweight rating. Of the remaining, 0 recommended UNCY as a Hold, 2 felt it is a Buy and 0 rated the stock as Underweight.

Unicycive Therapeutics Inc (NASDAQ:UNCY) trade information

Instantly UNCY was in red as seen at the end of in last trading. With action -30.26%, the performance over the past five days has been red. The company’s shares are showing year-to-date downside of -33.00%, with the 5-day performance at -30.26% in the red. However, in the 30-day time frame, Unicycive Therapeutics Inc (NASDAQ:UNCY) is -3.25% down.

Unicycive Therapeutics Inc (UNCY) estimates and forecasts

Looking at the company’s year-on-year earnings, data shows that the past 5-year has an earnings growth rate of -31.80%. The 2025 estimates are for Unicycive Therapeutics Inc earnings to increase by 70.74%.

Unicycive Therapeutics Inc (NASDAQ:UNCY)’s Major holders

LOGOS GLOBAL MANAGEMENT LP holds the second largest percentage of outstanding shares, with 9.9389% or 3.47 million shares worth $1.74 million as of 2024-06-30.

Among Mutual Funds, the top two as of Mar 31, 2025 were VANGUARD INDEX FUNDS-Vanguard Total Stock Market Index Fund and VANGUARD INDEX FUNDS-Vanguard Extended Market Index Fund. With 765.0 shares estimated at $0.41 million under it, the former controlled 0.63% of total outstanding shares. On the other hand, VANGUARD INDEX FUNDS-Vanguard Extended Market Index Fund held about 0.37% of the shares, roughly 447.44 shares worth around $0.24 million.